Peter Langecker's Net Worth

-$11.9 Thousand

Estimate Recalculated May 30, 2025 08:59PM EST

Who is Peter Langecker?

Peter Langecker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DURECT CORP, XCYTE THERAPIES INC, OXIGENE INC, and INTARCIA THERAPEUTICS, INC.

SEC CIK

Peter Langecker's CIK is 0001282829

Past Insider Trading and Trends

2009 was Peter Langecker's most active year for acquiring shares with 5 total transactions. Peter Langecker's most active month to acquire stocks was the month of December. 2013 saw Peter Langecker paying a total of $13,822.00 for 86,326 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DURECT CORP (DRRX) Snapshot price: $1.5699

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
Jan 27
Form 4
—
0
—
—
0
Jan 18
Form 4
—
0
—
—
0
Jan 24
Form 4
—
0
—
—
0
Jan 11
Form 4
—
0
—
—
0
May 1
Form 3
—
0
—
—
0
No matching records found

XCYTE THERAPIES INC (CYCC) Snapshot price: $1.02

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 17
Form 4
+150.00%
3K
$1.88
$5,627.70
5K
Feb 4
Form 4
∞
2K
$4.25
$8,500.00
2K
Jun 22 - Jun 24
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

OXIGENE INC (OTLC) Snapshot price: $0.02296

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1,459.86%
72.99K
—
—
77.99K
Aug 8
Form 4
+150.00%
3K
$2.75
$8,250.00
5K
Jun 28
Form 4
∞
2K
$2.79
$5,572.00
2K
Jun 25
Form 4
—
0
—
—
0
Feb 27
Form 4
—
0
—
—
0
Jul 30
Form 4
—
0
—
—
0
Dec 8
Form 4
—
0
—
—
0
Sep 15
Form 4
—
0
—
—
0
Apr 27
Form 4
—
0
—
—
0
Jun 29
Form 3
—
0
—
—
0
No matching records found

INTARCIA THERAPEUTICS, INC No price found

VP Research & Chief M.O.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found